Your browser doesn't support javascript.
loading
Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin.
Santalices, Irene; Vázquez-Vázquez, Carlos; Santander-Ortega, Manuel J; Lozano, Victoria; Araújo, Francisca; Sarmento, Bruno; Shrestha, Neha; Préat, Veronique; Chenlo, Miguel; Alvarez, Clara V; Benetti, Federico; Cuñarro, Juan; Tovar, Sulay; Torres, Dolores; Alonso, María José.
Afiliación
  • Santalices I; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
  • Vázquez-Vázquez C; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
  • Santander-Ortega MJ; Department of Physical Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
  • Lozano V; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.
  • Araújo F; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain.
  • Sarmento B; Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.
  • Shrestha N; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain.
  • Préat V; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
  • Chenlo M; Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
  • Alvarez CV; Instituto de Investigacão E Formacão Avançada Em Ciências E Tecnologias da Saúde (CESPU), 4585-116, Gandra, Portugal.
  • Benetti F; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium.
  • Cuñarro J; Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium.
  • Tovar S; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain.
  • Torres D; Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain.
  • Alonso MJ; ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy.
Drug Deliv Transl Res ; 11(2): 546, 2021 Apr.
Article en En | MEDLINE | ID: mdl-33742417
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Drug Deliv Transl Res Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Drug Deliv Transl Res Año: 2021 Tipo del documento: Article País de afiliación: España